Insider Selling at Avexis (AVXS) Continues with Significant Sale

Thursday, January 04, 2018 10:15 PM ET

Insider Selling at Avexis (AVXS) Continues with Significant Sale

An insider sold 15,000 shares of Avexis having a market value of approximately $1,646,212 today, as revealed in a form 4 document filed with the SEC. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 45,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 60,000 shares and have averaged 30,000 shares per transaction over this time period.

Over the last 90 days, the number of insider buy/sell trades at Avexis is greater than its 279-company peer group average. The Bio Therapeutic Drugs peer group saw 308 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares traded per transaction by Avexis insiders is lower than its peers. Within the peer group there were 42,508,637 shares purchased and 37,288,749 shares sold with company insiders acquiring 26,231 shares on average over this time period.

Insider buying and selling activity that is significant has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in composing and writing this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.